Drug Shortage Report for COUMADIN TAB 1MG
Report ID | 51516 |
Drug Identification Number | 01918311 |
Brand name | COUMADIN TAB 1MG |
Common or Proper name | Warfarin |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | WARFARIN SODIUM |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BTL X 100 |
ATC code | B01AA |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-08-23 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-08-20 |
Shortage status | Avoided shortage |
Updated date | 2018-08-21 |
Company comments | Stock will be allocated until the new lot arrives in Aug. 2018. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-05 | English | Compare |
v2 | 2018-06-05 | French | Compare |
v3 | 2018-08-14 | English | Compare |
v4 | 2018-08-17 | English | Compare |
v5 | 2018-08-17 | French | Compare |
v6 | 2018-08-21 | English | Compare |
v7 | 2018-08-21 | French | Compare |
Showing 1 to 7 of 7